Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Buy
5,698
+435
+8% +$55K ﹤0.01% 881
2026
Q1
$567K Buy
5,263
+838
+19% +$94.3K ﹤0.01% 964
2025
Q4
$500K Buy
4,425
+35
+0.8% +$3.34K ﹤0.01% 954
2025
Q3
$358K Sell
4,390
-100
-2% -$9.18K ﹤0.01% 1082
2025
Q2
$464K Buy
4,490
+647
+17% +$60.7K ﹤0.01% 978
2025
Q1
$378K Buy
3,843
+210
+6% +$28K ﹤0.01% 1017
2024
Q4
$545K Buy
3,633
+426
+13% +$58.7K 0.01% 930
2024
Q3
$418K Buy
3,207
+89
+3% +$11.1K ﹤0.01% 994
2024
Q2
$369K Buy
3,118
+241
+8% +$25.6K ﹤0.01% 1000
2024
Q1
$271K Sell
2,877
-2
-0.1% -$179 ﹤0.01% 1091
2023
Q4
$229K Buy
2,879
+113
+4% +$7.71K ﹤0.01% 1120
2023
Q3
$208K Buy
+2,766
New +$207K ﹤0.01% 1111
2021
Q3
Sell
-2,756
Closed -$234K 1203
2021
Q2
$234K Buy
+2,756
New +$226K ﹤0.01% 1131

Other funds holding GKOS

Xponance's GKOS Position: Q2 2026 in Review

Xponance increased its Glaukos (GKOS) stake by 8.3% in Q2 2026, buying an estimated $55K and bringing the position to 5,698 shares worth $796K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Xponance first reported a position in GKOS in Q2 2021 and has held it in 13 quarters since. 366 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Xponance held 5,698 shares of Glaukos worth $796K as of Q2 2026.
  • Xponance bought 435 Glaukos shares in Q2 2026, an estimated $55K.
  • Glaukos made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #881 holding.
  • Xponance first reported a position in Glaukos in Q2 2021 and has held it in 13 quarters since.
  • 366 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.